Protalix BioTherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. 

CEO
Dror Bashan
CEODror Bashan
Employees
208
Employees208
Headquarters
Hackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded
1993
Founded1993
Employees
208
Employees208

PLX Key Statistics

Market cap
83.28M
Market cap83.28M
Price-Earnings ratio
13.38
Price-Earnings ratio13.38
Dividend yield
—
Dividend yield—
Average volume
373.43K
Average volume373.43K
High today
$1.19
High today$1.19
Low today
$1.13
Low today$1.13
Open price
$1.18
Open price$1.18
Volume
228.48K
Volume228.48K
52 Week high
$3.55
52 Week high$3.55
52 Week low
$1.09
52 Week low$1.09

PLX News

Yahoo Finance 1d
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024 - Yahoo Finance

Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel, May 3, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX),...

Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024 - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.